Exelixis and Invenra expand partnership to develop cancer antibodies
Exelixis and Invenra have extended their discovery and licensing partnership to include 20 more oncology...
Sinopharm signs with Bangladesh to jointly produce COVID-19 vaccines
Chinese pharmaceutical giant Sinopharm has signed an agreement with Bangladesh over the co-production of COVID-19...
Seagen and RemeGen enter up to $2.6bn deal for cancer drug
Seagen and a Chinese company, RemeGen, have signed an exclusive global licencing agreement to develop...
Heraeus completes multi-million Euro cancer therapy API capacity expansion
Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs)...
Next Generation Automation Lab Achieves Huge Productivity Gains
Eli Lilly and Company and their industry partners, including sample management specialists – Ziath, are...
Takeda and Frazier Healthcare Announce Collaboration to Launch HilleVax to Develop Clinical Stage Norovirus...
Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners announced a collaboration to launch HilleVax, Inc....
GSK and Vir Biotechnology announce Joint Procurement Agreement with European Commission for COVID-19 treatment,...
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a Joint Procurement Agreement with...
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality...
Abzena and BioXpress Therapeutics announce partnership to support the development and manufacture of biosimilars...
Abzena, a Global Partner Research Organization for integrated bench to patient solutions for biologics and...
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC Protein Degrader ARV-471
Arvinas, Inc. and Pfizer Inc. announced a global collaboration to develop and commercialize ARV-471, an...
